Dr. Yogesh Harwani was honored to be invited to ENDOCON 2025, the annual meeting of the Society of GI Endoscopy of India, held in Jaipur. At the prestigious conference, he had the opportunity to deliver two significant talks: one on the selection of patients for endoscopic treatment for GERD, and another on the role of intragastric balloon for obesity in 2025.
Endocon 2025 Jaipur, organized by SGEI, brought together top experts and practitioners in gastroenterology—as well as rising stars in the field of GI endoscopy India innovations. The conference featured live endoscopy sessions, post-graduate workshops, and deep dives into procedures like POEM, ESD, and STER. It became visible as a key platform for both experienced endoscopists and emerging practitioners.
In his first talk, Dr. Harwani emphasized that endoscopic management of GERD is here to stay. He explained how minimally invasive GERD treatment and advanced endoscopic therapies for GERD are becoming preferred choices for appropriately selected patients. As outpatient day care endoscopy procedures for GERD continue to expand, gastroenterologists across India are adopting these newer protocols with better outreach and improved patient compliance.
During his second presentation, Dr. Harwani introduced the concept of combination therapy obesity endoscopy—using anti-obesity drugs with intragastric balloon placement or endoscopic sleeve gastroplasty. This approach is shaping the future of obesity treatment intragastric balloon solutions in India. He argued that for class I and II obesity, these minimally invasive options, especially in combination with medical therapy, represent the next frontier in weight management.
Endoscopic GERD management is gaining prominence, and the future of obesity management endoscopy lies in integrated treatment protocols including balloons and medications.
As illustrated at the SGEI annual meeting Endocon, outpatient endoscopy focused on GERD is expanding rapidly in India, aligning with demand for safer, more convenient care.
Intragastric balloon obesity therapy is emerging as a valuable alternative to surgery, with growing adoption in urban centers and clinical practice.
Patients dealing with GERD now have access to effective endoscopic treatments that offer minimal downtime and fewer side effects than surgery. Rather than traditional anti-reflux surgery, patients may benefit from precise endoscopic options at Jaipur and beyond.
For patients facing early obesity issues, the combination of anti-obesity drugs with intragastric balloon or endoscopic sleeve gastroplasty presents a promising alternative—offering safe, reversible, and effective outcomes.
| Aspect | Summary |
|---|---|
| Event | ENDOCON 2025 – Society of GI Endoscopy of India at Jaipur |
| Speaker | Dr. Yogesh Harwani – Gastroenterologist with expertise in endoscopy |
| Topics Covered | GERD patient selection; intragastric balloon therapy for obesity |
| Learning Outcome | Advanced GERD care; emerging bariatric endoscopy methods |
| Regional Relevance | Strong interest from endoscopic GERD specialists India and beyond |
Dr. Harwani extended his sincere thanks to Dr. Abhinav Sharma, Dr. Dinesh Aggrawal, and the entire Endocon 2025 organizing committee for their support and invitation.
Day care endoscopy procedures growth is rapidly changing hospital and clinic workflows, making GI care more efficient and patient-friendly.
Industry reports show intragastric balloon industry trend India is on the rise, particularly in clinics offering bariatric alternatives.
Innovative trends in endoscopic bariatric therapies are reshaping how obesity is addressed in gastroenterology.
Dr. Harwani is known for his clinical expertise in GI and bariatric endoscopy and is a leading name among GI endoscopy experts in India. His practice focuses on endoscopic procedures with a strong emphasis on outpatient care, minimally invasive approaches, and patient safety. He is recognized as a Dr. Yogesh Harwani GERD expert and Dr. Yogesh Harwani obesity endoscopy specialist, and regularly leads endoscopy meeting in India and workshops.
Endoscopic sleeve gastroplasty future holds great promise for non-surgical weight loss interventions.
Conferences like Endocon 2025 scientific programme serve as platforms for clinicians to stay updated on GI endoscopy conference India insights, including emerging trends and patient selection criteria.
Clinicians should follow upcoming endoscopy for class I II obesity protocols and safe and rational endoscopy practices to better integrate endoscopic techniques in routine care.
Dr. Harwani highlighted the importance of building growth plan for hospitals by integrating minimally invasive procedures into gastroenterology and bariatric services. Hospitals and clinics focusing on online marketing for hospitals and digital marketing for hospitals now have the opportunity to highlight services like endoscopic GERD care and intragastric balloon therapy—positioning themselves as progressive healthcare providers in India.
Dr. Yogesh Harwani’s participation at Endocon 2025 Jaipur underscores his commitment to advancing endoscopic management of GERD, promoting surgical‑free obesity therapies, and sharing knowledge about endoscopic GERD 2025 treatments and obesity endoscopy trends in India.
If you’re interested in learning more or consulting Dr. Harwani on GERD or intragastric balloon therapy, contact Noble Gastro Hospital in Ahmedabad today.
